Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
LMNA-NTRK1 fusion
i
Other names:
LMNA, Prelamin-A/C, LMN1, Mandibuloacral dysplasia type A, Limb girdle muscular dystrophy 1B (autosomal dominant), Cardiomyopathy dilated 1A (autosomal dominant), Lamin A/C, FPLD2, LGMD1B, CMT2B1, Renal carcinoma antigen NY-REN-32, Progeria 1 (hutchinson-gilford type), NTRK1, MTC, TRK, TRKA, Neurotrophic tyrosine kinase, receptor, type 1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4914
;
4000
Related biomarkers:
Expression
Mutation
Fusion
Others
‹
NTRK1 positive (2)
NTRK1 overexpression (1)
NTRK1 positive (2)
NTRK1 overexpression (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
LMNA-NTRK1 fusion
Breast Cancer
LMNA-NTRK1 fusion
Breast Cancer
larotrectinib
Sensitive: C3 – Early Trials
larotrectinib
Sensitive
:
C3
larotrectinib
Sensitive: C3 – Early Trials
larotrectinib
Sensitive
:
C3
LMNA-NTRK1 fusion
Soft Tissue Sarcoma
LMNA-NTRK1 fusion
Soft Tissue Sarcoma
larotrectinib
Sensitive: C4 – Case Studies
larotrectinib
Sensitive
:
C4
larotrectinib
Sensitive: C4 – Case Studies
larotrectinib
Sensitive
:
C4
LMNA-NTRK1 fusion
Breast Cancer
LMNA-NTRK1 fusion
Breast Cancer
ceritinib
Sensitive: D – Preclinical
ceritinib
Sensitive
:
D
ceritinib
Sensitive: D – Preclinical
ceritinib
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.